CD8A and neoplasm: In both experiments, tethered and untethered IL-12 mRNA-based intratumorally delivered treatments were able to elicit antigen-specific CD8+ T cell-mediated systemic immunity toward antigens of the tumor cell lines, compared with irrelevant mRNA-injected mice (Figures S8A–S8C).